Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benoxaprofen, (+)-isomer
2. Benoxaprofen, (+-)-isomer
3. Benoxaprofen, (-)-isomer
4. Benoxaprofen, Ammonium Salt
5. Benoxaprofen, Monosodium Salt
6. Lrcl 3794
7. Oraflex
1. 51234-28-7
2. Uniprofen
3. Oraflex
4. Coxigon
5. Opren
6. Inflamid
7. Dl-benoxaprofen
8. Compound 90459
9. Benoxaprofene
10. Benoxaprofenum
11. Benoxaprofeno
12. 2-(2-(4-chlorophenyl)benzo[d]oxazol-5-yl)propanoic Acid
13. Lilly 90459
14. 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic Acid
15. (+-)-benoxaprofen
16. 2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
17. (1)-2-(4-chlorophenyl)benzoxazole-5-propionic Acid
18. Nsc 299582
19. Chebi:76114
20. 5-benzoxazoleacetic Acid, 2-(4-chlorophenyl)-.alpha.-methyl-
21. Nsc-299582
22. 17szx404im
23. 2-(p-chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic Acid
24. Compd 90459
25. Nsc299582
26. 2-(2-(4-chlorophenyl)-1,3-benzoxazol-5-yl)propanoic Acid
27. Benoxaprofene [inn-french]
28. Benoxaprofenum [inn-latin]
29. Benoxaprofeno [inn-spanish]
30. 2-(p-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
31. Benoxaprofen [usan:inn:ban]
32. Lrcl 3794
33. Oraflex (tn)
34. 67434-14-4
35. Einecs 257-069-7
36. Benoxaprofen (usan/inn)
37. Brn 1085080
38. Unii-17szx404im
39. (+-)-2-(p-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
40. (rs)-benoxaprofen
41. Einecs 266-692-3
42. (+/-)-benoxaprofen
43. Benoxaprofen [mi]
44. Benoxaprofen [inn]
45. Benoxaprofen [jan]
46. Benoxaprofen [usan]
47. Schembl24413
48. Benoxaprofen [mart.]
49. Compound-90459
50. Benoxaprofen [who-dd]
51. Chembl340978
52. Dtxsid4022650
53. (+-)-2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
54. 5-benzoxazoleacetic Acid, 2-(4-chlorophenyl)-alpha-methyl, (+-)-
55. Bdbm50088388
56. Db04812
57. Da-05331
58. Hy-13568
59. Cs-0007198
60. Ft-0662523
61. Ft-0662524
62. C90147
63. D03080
64. A905882
65. Q420082
66. 2-(4-chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic Acid
67. 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic Acid #
68. (alphar)-2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
69. (alphas)-2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic Acid
70. (+/-)-2-(p-chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic Acid
71. (.+/-.)-2-(p-chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic Acid
72. 5-benzoxazoleacetic Acid, 2-(4-chlorophenyl)-.alpha.-methyl, (.+/-.)-
73. 5-benzoxazoleacetic Acid, 2-(4-chlorophenyl)-.alpha.-methyl, (+/-)-
Molecular Weight | 301.72 g/mol |
---|---|
Molecular Formula | C16H12ClNO3 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 301.0505709 g/mol |
Monoisotopic Mass | 301.0505709 g/mol |
Topological Polar Surface Area | 63.3 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 384 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Lipoxygenase Inhibitors
Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AE - Propionic acid derivatives
M01AE06 - Benoxaprofen
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?